Author:
Yono Makoto,Foster, Jr. Harris E,Shin David,Takahashi Wataru,Pouresmail Mehdi,Latifpour Jamshid
Abstract
α1-adrenoceptor (AR) antagonists can provide effective treatment of symptoms caused by benign prostatic hyperplasia. However, their mechanisms of action have not been fully elucidated. We previously reported that chronic administration of doxazosin causes an up-regulation in the mRNA expression of all three α1-AR subtypes in the rat prostate. As α1-AR antagonists might also affect the properties of α1-ARs in the lower urinary tract, we examined the effects of doxazosin (2 or 4 mg/kg daily subcutaneously, supplemented with 4 mg/kg daily orally for 8 or 12 weeks) on α1-AR subtype mRNAs in the rat bladder dome, bladder base, and urethra using real-time reverse transcription PCR. Rats that received the highest doses of doxazosin had significantly heavier bladder base and prostatic urethra than controls. PCR data showed that all three α1-AR subtypes were expressed in all tissues studied. Doxazosin treatment caused an up-regulation in the mRNA levels of α1A-AR in the rat bladder base and prostatic urethra, indicating that chronic doxazosin treatment may cause an alteration in the properties of α1A-AR subtype mRNA in these two areas. Furthermore, the heavier bladder base and prostatic urethra in the doxazosin-treated rats suggest that α1-AR antagonist treatment might also influence the growth process in these areas of the rat lower urinary tract.Key words: α1-adrenoceptor, doxazosin, bladder, urethra.
Publisher
Canadian Science Publishing
Subject
Physiology (medical),Pharmacology,General Medicine,Physiology
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pharmacology of the Lower Urinary Tract;Handbook of Neurourology;2023
2. Neuroanatomy and Neurophysiology;Female Genitourinary and Pelvic Floor Reconstruction;2023
3. Neuroanatomy and Neurophysiology;Female Genitourinary and Pelvic Floor Reconstruction;2022
4. Pharmacology of the Lower Urinary Tract;Handbook of Neurourology;2022
5. Pharmacology of the Lower Urinary Tract;Neurourology;2019